Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19294142 | 0.84 | — | — | |
| SCHEMBL17131434 | 0.84 | — | — | |
| SCHEMBL16420319 | 0.84 | — | — | |
| SCHEMBL16420320 | 0.80 | GAA (0.37) | KDM4EALDH1A1GAAHPGD | |
| SCHEMBL17131433 | 0.76 | KDM4E (0.31) | KDM4EALDH1A1GAAHPGD | |
| SCHEMBL16420339 | 0.76 | — | — | |
| SCHEMBL16420337 | 0.76 | KDM4E (0.32) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL16420343 | 0.74 | KDM4E (0.36) | KDM4EALDH1A1GAAHPGD | |
| SCHEMBL16727549 | 0.74 | KDM4E (0.36) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL19294143 | 0.74 | KDM4E (0.33) | KDM4EALDH1A1GAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10930866-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-23 | — | — | US | disclosed |
| US-20200176694-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-06-04 | — | — | US | disclosed |
| US-20170250354-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-08-31 | — | — | US | disclosed |
| US-9748504-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-08-29 | — | — | US | disclosed |
| US-9748504-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-08-29 | — | — | US | disclosed |
| US-20150280146-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-10-01 | — | — | US | disclosed |
| US-20150028290-A1 | HETEROLEPTIC OSMIUM COMPLEX AND METHOD OF MAKING THE SAME | UNIVERSAL DISPLAY CORPORATION (US) | 2015-01-29 | — | — | US | disclosed |
| US-20150028290-A1 | HETEROLEPTIC OSMIUM COMPLEX AND METHOD OF MAKING THE SAME | UNIVERSAL DISPLAY CORPORATION (US) | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10930866-B2 | Organic electroluminescent materials and devices | OSBPL3, OR10J3, OSBP2 | KDM4E 3560/4885ALDH1A1 1215/4885GLA 2592/4885 |
| US-20150280146-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, SSB, RO60 | KDM4E 2698/4885ALDH1A1 2401/4885GLA 1672/4885 |
| US-20200176694-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBPL3, OR10J3, OSBP2 | KDM4E 3560/4885ALDH1A1 1215/4885GLA 2592/4885 |
| US-20170250354-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBPL3, OR10J3, OSBP2 | KDM4E 3560/4885ALDH1A1 1215/4885GLA 2592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.